
None yet
None yet
Discussion around Valeant's leverage at the JPM Healthcare Conference, with management indicating a strategy to deleverage quickly despite a seemingly high tolerance for leverage.
Main discussion
No comments yet.
Facts and opinions separated · All items sourced · Not investment advice